| Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas TY Seiwert, Z Zuo, MK Keck, A Khattri, CS Pedamallu, T Stricker, C Brown, ... Clinical cancer research 21 (3), 632-641, 2015 | 661 | 2015 |
| Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study EEW Cohen, DW Davis, TG Karrison, TY Seiwert, SJ Wong, S Nattam, ... The lancet oncology 10 (3), 247-257, 2009 | 324 | 2009 |
| OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer TY Seiwert, CC Foster, EA Blair, TG Karrison, N Agrawal, JM Melotek, ... Annals of Oncology 30 (2), 297-302, 2019 | 199 | 2019 |
| Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer CM Lennard, A Patel, J Wilson, B Reinhardt, C Tuman, C Fenton, E Blair, ... Surgery 129 (5), 552-558, 2001 | 199 | 2001 |
| Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial WN William, V Papadimitrakopoulou, JJ Lee, L Mao, EEW Cohen, HY Lin, ... JAMA oncology 2 (2), 209-216, 2016 | 141 | 2016 |
| A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck JA De Souza, DW Davis, Y Zhang, A Khattri, TY Seiwert, S Aktolga, ... Clinical Cancer Research 18 (8), 2336-2343, 2012 | 119 | 2012 |
| Chemoradiation for patients with advanced oral cavity cancer KM Stenson, R Kunnavakkam, EEW Cohen, LD Portugal, E Blair, ... The Laryngoscope 120 (1), 93-99, 2010 | 119 | 2010 |
| Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer EEW Cohen, DJ Haraf, R Kunnavakkam, KM Stenson, EA Blair, ... Journal of clinical oncology 28 (20), 3336, 2010 | 101 | 2010 |
| Sealed rupture of abdominal aortic aneurysms AV Sterpetti, EA Blair, RD Schultz, RJ Feldhaus, S Cisternino, P Chasan Journal of vascular surgery 11 (3), 430-435, 1990 | 95 | 1990 |
| Plerixafor for the treatment of WHIM syndrome DH McDermott, DV Pastrana, KR Calvo, S Pittaluga, D Velez, E Cho, ... New England Journal of Medicine 380 (2), 163-170, 2019 | 89 | 2019 |
| Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to: MAML2: Rearrangement and Prognosis NA Cipriani, JJ Lusardi, J McElherne, AT Pearson, AD Olivas, ... The American journal of surgical pathology 43 (7), 885-897, 2019 | 88 | 2019 |
| Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer VM Villaflor, JM Melotek, TG Karrison, RJ Brisson, EA Blair, L Portugal, ... Annals of Oncology 27 (5), 908-913, 2016 | 85 | 2016 |
| Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation KS Choe, DJ Haraf, A Solanki, EEW Cohen, TY Seiwert, KM Stenson, ... Cancer 117 (20), 4671-4678, 2011 | 85 | 2011 |
| A phase II study of lapatinib (GW572016) in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) OO Abidoye, EE Cohen, SJ Wong, MF Kozloff, SR Nattam, KM Stenson, ... Journal of Clinical Oncology 24 (18_suppl), 5568-5568, 2006 | 84 | 2006 |
| Minor salivary gland inflammation in Devic’s disease and longitudinally extensive myelitis A Javed, R Balabanov, BGW Arnason, TJ Kelly, NJ Sweiss, P Pytel, ... Multiple Sclerosis Journal 14 (6), 809-814, 2008 | 80 | 2008 |
| Planned post‐chemoradiation neck dissection: significance of radiation dose KM Stenson, D Huo, E Blair, EEW Cohen, A Argiris, DJ Haraf, EE Vokes The Laryngoscope 116 (1), 33-36, 2006 | 78 | 2006 |
| A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily … JK Salama, DJ Haraf, KM Stenson, EA Blair, ME Witt, R Williams, ... Annals of oncology 22 (10), 2304-2309, 2011 | 76 | 2011 |
| Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy EEW Cohen, J Baru, D Huo, DJ Haraf, M Crowley, ME Witt, EA Blair, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2009 | 76 | 2009 |
| Identification of abdominal aortic aneurysm patients with different clinical features and clinical outcomes AV Sterpetti, RJ Feldhaus, RD Schultz, EA Blair The American Journal of Surgery 156 (6), 466-469, 1988 | 72 | 1988 |
| Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies AW Pederson, JK Salama, DJ Haraf, ME Witt, KM Stenson, L Portugal, ... Head & neck oncology 3, 1-6, 2011 | 61 | 2011 |
Ezra CohenUniversity of California San DiegoBestätigte E-Mail-Adresse bei health.ucsd.edu
